Literature DB >> 20091892

The impact of using defined criteria for adequacy of fine needle aspiration cytology of the thyroid in routine practice.

Asma S Haider1, Emad A Rakha, Christine Dunkley, Abed M Zaitoun.   

Abstract

The fine needle aspiration cytology (FNAC) of the thyroid is the predominant method of preoperative tissue diagnosis of thyroid lesions. The routine use of FNAC has reduced the rate of unnecessary surgery for thyroid nodules. However, there are overlaps in the existing criteria for defining adequacy in thyroid aspirates. In this study, we aimed to explore the reasons for high percentage of inadequate thyroid FNAC samples and to reevaluate those samples by applying clearly defined criteria suggested in the literature to reduce the proportion of inadequate aspirates. The results of 550 smears reported as inadequate FNAC samples are presented over a period of 15 years extending from 1986 to 2000 (18.8%). For the purpose of the study, only those patients with subsequent histological or cytological analysis were included (279). The original FNA samples were reviewed by two cytopathologists, unaware of the subsequent repeat cytology or histology results. Specific criteria for adequacy of specimens were used which include the presence of six or more groups of follicular cells, each having more than 10 discernable viable cells or 60 isolated viable follicular cells. Out of 279, 82 (29%) FNAC samples originally reported as inadequate met our criteria and were considered adequate on review. Of these 82 cases, subsequent surgical excision showed malignancy in 5 cases (6%), adenoma in 7 (9%), and benign hyperplasia and thyroiditis in 70 cases (85%). In addition, 16 (5%) cases were classified as cysts. The slide preparation error was noticed in 26 (14%) and the sampling error was observed in 160 (86%) cases. The use of well-defined criteria for adequacy is helpful because it improves the diagnostic efficiency of thyroid FNA and avoids unnecessary surgery for benign nonneoplastic thyroid lesions. However, since application of these criteria has also resulted in an increase in the false-negative diagnoses, they should be applied in the multidisciplinary context.
Copyright © 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20091892     DOI: 10.1002/dc.21324

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  5 in total

1.  The bethesda system for reporting thyroid cytopathology: a five-year retrospective review of one center experience.

Authors:  Shagufta Tahir Mufti; Rihab Molah
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

Review 2.  Effectiveness and limitations of core needle biopsy in the diagnosis of thyroid nodules: review of current literature.

Authors:  Jung Hyun Yoon; Eun-Kyung Kim; Jin Young Kwak; Hee Jung Moon
Journal:  J Pathol Transl Med       Date:  2015-05-15

3.  Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.

Authors:  Sherry Bhalla; Harpreet Kaur; Rishemjit Kaur; Suresh Sharma; Gajendra P S Raghava
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

4.  Evaluation of malignancy with thyroid imaging reporting and data system (TI-RADS) in thyroid nodules with persistent nondiagnostic cytology

Authors:  Hüsniye Başer; Oya Topaloğlu; Sevgul Fakı; Afra Alkan; Mustafa Ömer Yazıcıoğlu; Hayriye Tatlı Doğan; İbrahim Kılınç; Reyhan Ersoy; Bekir Çakır
Journal:  Turk J Med Sci       Date:  2019-06-18       Impact factor: 0.973

5.  Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance.

Authors:  You-Bin Lee; Ji-Ye Kim; Haeyon Cho; Soo Yeon Hahn; Jung Hee Shin; Seung-Eun Lee; Ji Eun Jun; Sun Wook Kim; Jae Hoon Chung; Tae Hyuk Kim; Young Lyun Oh
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.